Rangwala Reshma (CIK 0001825322)

Latest company ownership

KPTI - Karyopharm Therapeutics Inc.

Role: EVP & Chief Medical Officer

Shares held

29,390

Last filed at

Sep 16, 2025

Confidence Score

55.0

2025Q4

Confidence Score History

2023Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 12, 2025	Sep 16, 2025	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	77.5	+537	1.86%	✗	$2.6K
Apr 23, 2025	Apr 24, 2025	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	47.5	-419	-1.43%	✗	$2.6K
Mar 4, 2025	Mar 6, 2025	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	46.3	-3,587	-10.92%	✗	$22.6K
Apr 22, 2024	Apr 23, 2024	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	47.5	-6,789	-1.94%	✗	$7.9K
Feb 29, 2024	Mar 4, 2024	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	46.3	-21,636	-5.83%	✗	$25.5K
Apr 20, 2023	Apr 24, 2023	Karyopharm Therapeutics Inc.	EVP & Chief Medical Officer	Sell	46.3	-6,770	-4.10%	✗	$27.4K